HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term effects of the rhapontic rhubarb extract ERr 731® on estrogen-regulated targets in the uterus and on the bone in ovariectomized rats.

Abstract
The efficacy of ERr 731(®), a commercially available extract isolated from Rheum rhaponticum, in terms of menopausal complaints like hot flushes, depression, anxiety and vaginal dryness has been proven in a two-year clinical study. Further a recent preclinical study excluded unwanted side effects on the endometrium by showing a lack of stimulation of proliferation marker genes by ERr 731(®) or its constituents in the 3-day uterotrophic assay. The present study aimed at further substantiating the safety of ERr 731(®) in terms of endometrial hyperplasia and at the same time test for potential estrogenic effects in the bone. Therefore, ovariectomized (ovx) rats were treated in a dietary long-term administration for 90 days. Hence, the modulation of proliferation in the uterus was investigated by examining the effects on the mRNA expression of proliferation marker genes (Mki67, Pcna), on the estrogen-responsive gene C3 and on the estrogen receptors ERα and ERβ. We additionally performed densitometry analysis of the proximal tibia metaphysis using peripheral computed tomography (pQCT) and quantified bone homeostasis markers in the serum to examine potential effects on the bone. In this study design, neither an uterotrophic response nor a modulation of proliferation marker genes on mRNA level has been observed as response to the long-term application of the rhapontic extract. Furthermore, no impact of the two administered ERr 731(®) doses on the E2 deprivation-induced bone loss has been evident at the end of the study. In conclusion, the observations from previous trials regarding the endometrial safety of ERr 731(®) have been supported by our experimental findings that exclude a stimulatory activity on proliferation in the uterus in a long-term administration in the young adult rat but no effect on the bone mineral density could be observed.
AuthorsAnnekathrin Martina Keiler, Anja Papke, Georg Kretzschmar, Oliver Zierau, Günter Vollmer
JournalThe Journal of steroid biochemistry and molecular biology (J Steroid Biochem Mol Biol) Vol. 128 Issue 1-2 Pg. 62-8 (Jan 2012) ISSN: 1879-1220 [Electronic] England
PMID21946530 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Bone Density Conservation Agents
  • Collagen Type I
  • Complement C3
  • ERr 731
  • Estrogens
  • Ki-67 Antigen
  • Plant Extracts
  • Proliferating Cell Nuclear Antigen
  • Osteocalcin
  • estradiol 3-benzoate
  • Estradiol
Topics
  • Animals
  • Bone Density (drug effects)
  • Bone Density Conservation Agents (adverse effects, pharmacology, therapeutic use)
  • Cell Proliferation (drug effects)
  • Collagen Type I (blood)
  • Complement C3 (genetics, metabolism)
  • Endometrium (drug effects, growth & development)
  • Estradiol (analogs & derivatives, pharmacology)
  • Estrogens (pharmacology, physiology)
  • Female
  • Gene Expression (drug effects)
  • Humans
  • Ki-67 Antigen (genetics, metabolism)
  • Menopause
  • Organ Size
  • Osteocalcin (blood)
  • Ovariectomy
  • Plant Extracts (adverse effects, pharmacology, therapeutic use)
  • Proliferating Cell Nuclear Antigen (genetics, metabolism)
  • Rats
  • Rats, Wistar
  • Rheum (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: